CSIMarket Company Name, Ticker, Suppliers, else..


Renovorx Inc   (NASDAQ: RNXT)
Other Ticker:  
 

Renovorx Inc

RNXT's Fundamental analysis



Looking into Renovorx Inc growth rates, revenue grew in the fourth quarter of 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Renovorx Inc realized net income compared to net loss a year ago in fourth quarter of 2024

• More on RNXT's Growth


Renovorx Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.69 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1209.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.11.


• More on RNXT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4
 Tangible Book Value (Per Share $) 0.09

Renovorx Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 8.69 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1209.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.11.

Renovorx Inc Price to Book Ratio is at 11.61 lower than Industry Avg. of 76.68. and higher than S&P 500 Avg. of 0.01

• More on RNXT's Valuation

•  Market Capitalization (Millions $) 52
•  Shares Outstanding (Millions) 50
•  Employees -
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 6
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4
•  Tangible Book Value (Per Share $) 0.09

•  Market Capitalization (Millions $) 52
•  Shares Outstanding (Millions) 50
•  Employees -
•  Revenues (TTM) (Millions $) 0
•  Net Income (TTM) (Millions $) 0
•  Cash Flow (TTM) (Millions $) 6
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 4.1
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.81
•  Asset Turnover Ratio (TTM) 0
•  Inventory Turnover Ratio (TTM) -





Renovorx Inc net profit margin of 13804.65 % is currently ranking no. 1 in Major Pharmaceutical Preparations industry, ranking no. 1 in Healthcare sector and number 4 in S&P 500.

• More on RNXT's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com